WILLIAMS AND JENSEN, PLLC for MERCK & CO INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Payment policies for prescription drugs. Rebates for Medicare Part D. Independent Payment Advisory Board (IPAB).
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | COS, Rep. Van Hilleary and Majority Whip |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | Staff, Sente Special Com on Aging/ Gvt Affairs |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Health Issues HCR
Drug safety; Congressional oversight issues; Legislation concerning PSE; Implementation of Patient Protection and Affordable Care Act. House and Senate Budget. Compounding legislation. Work on 21st Century Cures Initiative. Issues related to vaccines. Drug pricing issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | COS,Rep.Van Hilleary and Majority Whip |
| MATTHEW B HOEKSTRA | — |
| CHERYL LYNN JAEGER New | Sr. LA to Rep. Christopher Cox |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Trade (domestic/foreign) TRD
International trade issues and agreements. Monitor pending trade issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | Senate Committees on Aging and Gov't Affairs |
| KARINA LYNCH | Sch., C, Treasury;LD, Rep. Scott McInnis |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax including international tax proposals. H.R. 2315 Preserving Access to Orphan Drugs Act. Tax application of the ACA Section 9008 to Orphan Drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| CHERYL LYNN JAEGER New | Sr. LA to Rep. Christopher Cox |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.